Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening

被引：46

作者：

Usui, Taikou ^{[1
]}

Ban, Hyun Seung ^{[1
]}

Kawada, Junpei ^{[1
]}

Hirokawa, Takatsugu ^{[2
]}

Nakamura, Hiroyuki ^{[1
]}

机构：

[1] Gakushuin Univ, Fac Sci, Dept Chem, Tokyo 1718588, Japan

[2] Inst Adv Ind Sci & Technol AIST, Computat Biol Res Ctr, Tokyo 1350064, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 01期

关键词：

D O I：

10.1016/j.bmcl.2007.10.084

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of indenopyrazoles 8 and 9 were designed and synthesized as EGFR tyrosine kinase inhibitors by in silico high-throughput screening. Compounds 8b and 8d showed significant inhibition of A431 cell growth (GI(50) = 0.062 and 0.057 mu M, respectively). Compounds 8b and 9a showed inhibitory activity toward both EGFR and VEGFR-2 (KDR) tyrosine kinases, whereas 8d inhibited VEGFR-2 tyrosine kinase, exclusively. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：285 / 288

页数：4

共 50 条

[1] High-throughput screening for kinase inhibitors
von Ahsen, O
Bömer, U
CHEMBIOCHEM, 2005, 6 (03) : 481 - 490
[2] Discovery of novel Benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors
Hasegawa, Masaichi
Nishigaki, Naohiko
Washio, Yoshiaki
Kano, Kazuya
Harris, Philip A.
Sato, Hideyuki
Mori, Ichiro
West, Rob I.
Shibahara, Megumi
Toyoda, Hiroko
Wang, Liping
Nolte, Robert T.
Veal, James M.
Cheung, Mui
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (18) : 4453 - 4470
[3] Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
Li, Yunqi
Tan, Chunyan
Gao, Chunmei
Zhang, Cunlong
Luan, Xudong
Chen, Xiaowu
Liu, Hongxia
Chen, Yuzong
Jiang, Yuyang
BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (15) : 4529 - 4535
[4] High-Throughput Screening for the Discovery of Enzyme Inhibitors
Lloyd, Matthew D.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 10742 - 10772
[5] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
Lv, Yongcong
Li, Mengyuan
Liu, Ting
Tong, Linjiang
Peng, Ting
Wei, Lixin
Ding, Jian
Xie, Hua
Duan, Wenhu
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
[6] The Discovery of Novel Protein Tyrosine Phosphatase ε Inhibitors Using a High-throughput Screening Approach
Yun, Hye-Yeoung
Ku, Bonsu
Lee, Hye Seon
Shin, Ho-Chul
Park, Jun-Beom
Kim, Chang Hyen
Kim, Seung Jun
BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2017, 38 (01) : 44 - 53
[7] 'In silico' repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms
Ibraheim, Mona H.
Maher, Ibrahim
Khater, Ibrahim
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (18): : 9571 - 9586
[8] Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase
Bhojwani, Heena R.
Joshi, Urmila J.
CURRENT COMPUTER-AIDED DRUG DESIGN, 2017, 13 (03) : 186 - 207
[9] De novo Design of Indole Derivatives as VEGFR-2 Tyrosine Kinase Inhibitors
Kang Congmin
Zhao Xuhao
Yu Yuqi
Lu Yingtao
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2014, 35 (03): : 550 - 554
[10] Streamlining lead discovery by aligning in silico and high-throughput screening
Davies, John W.
Glick, Meir
Jenkins, Jeremy L.
CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (04) : 343 - 351

← 1 2 3 4 5 →